Improving Patient Outcomes
Clinical Trials for Red Cells and Plasma
Day: Thursday | Time: 08:45 - 10:15
Session Coordinators:
Jonathan Wallis
Speakers:
Transfusion in the management of anaemia in Myelodysplastic Syndromes
Dr Dominic Culligan, Aberdeen
Pre-hospital plasma for Trauma in the North East
Dr Alex Langridge, Royal Victoria Infirmary, Newcastle upon Tyne
Cryostat 1 and 2
Dr Simon Stanworth, John Radcliffe Hospital
Fibrinogen Concentrate: Where and when
Dr Nicola Curry, Oxford University Hospitals
Intended Audience
BMSs, TPs, Haematologists
Learning Objectives
Transfusion threshold for Myelodysplasia. The place of fibrinogen concentrate in our haemostatic armoury. Use of pre-thawed plasma in the pre-hospital setting.
Brief Description
Transfusion in myelodysplasia, too much or too little? Results of the REDDS trial and the question of iron.Should we use plasma before or after red cells in trauma? Would we be better with plasma in addition or instead of red cells on board the helicopter? What is the role of fibrinogen concentrate in massive bleeding from any cause? Expert review of fiibrinogen concentrate use. Experience on board the trauma helicopter in the North east and evidence from cryostat1 and report from cryostat2.
Session Tags
Improving Patient Outcomes
